Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3086 of 6351
-
Dry needling shows promise for chronic back pain relief
Symptom relief CompletedThe proposed clinical study aims to evaluate the effectiveness and safety of adding Dry Needling (DN) to Conventional Treatment (CT) for patients with Myofascial Low Back Pain (MLBP). MLBP is a widespread musculoskeletal condition that causes localized pain, muscle tenderness, an…
Phase 4 • Sponsor: Dr. Vishwanath Karad MIT World Peace University • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New wheelchair training could give kids with severe CP a shot at independence
Symptom relief By invitation onlyFor children with severe cerebral palsy, a powered wheelchair (PWC) may provide their only option for functional mobility and independence. PWC use is often restricted to a small percentage of children who can quickly demonstrate proficient PWC skills within a single 30-minute PW…
Sponsor: Grand Valley State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Experimental drug aims to tame overactive platelet production
Disease control Recruiting nowThis is a multicenter, randomized, open-label Phase 2 clinical study. It is aimed to enroll 27 essential thrombocytopenia (ET) patients who are resistant to or intolerant of hydroxyurea(HU). Eligible patients will be randomized to receive either Peginterferon α-2b 135 mcg or Pegi…
Phase 2 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for advanced cancer: first human trial of ASD141 begins
Disease control Recruiting nowThis is a Phase I study designed to evaluate if ASD141 is safe, tolerable, and efficacious in participants with advanced solid tumors.
Phase 1 • Sponsor: Ascendo Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Supercharged immune cells take on advanced kidney and bladder tumors
Disease control OngoingThe goal of this research study is to establish the safety and then to explore the effectiveness of infusing the combination of cytokine-induced memory-like (CIML) natural killer (NK) cells, a type of immune cell in the blood that is collected and bathed in special proteins to he…
Early phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo takes on tough tumors
Disease control Recruiting nowThe purpose of this first-in-human study, CTMX-801-101, is to characterize the safety, tolerability, and antitumor activity of CX-801 as monotherapy and in combination with pembrolizumab in adult participants with advanced solid tumors.
Phase 1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New booklet aims to spark quit-smoking motivation in cancer patients
Symptom relief Recruiting nowThe purpose of this research study is assess feasibility and acceptability of a recently developed brief self-help intervention targeted by cancer type to increase motivation to quit smoking.
Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Free meals plus heart lessons may lower blood sugar and pressure in underserved communities
Disease control CompletedThis randomized clinical trial (RCT) will investigate novel approaches to enhance effectiveness, engagement, reach, and cost-effectiveness of medically tailored meals (MTM) programs for promoting cardiovascular health, focusing on economically disadvantaged New York City neighbor…
Sponsor: Columbia University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Hope dashed: drug trial for Post-COVID racing heart stopped early
Disease control Stopped earlyThis is a prospective, phase 3, multicenter, double-blind, randomized placebo-controlled study to investigate the efficacy, safety, and pharmacokinetics (PK) of repeat doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (…
Phase 3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo therapy targets hard-to-treat melanoma in early trial
Disease control OngoingA Phase 1b study to evaluate the safety and tolerability of MB097 given in combination with pembrolizumab in patients with melanoma who demonstrate primary resistance to anti-PD1 therapy.
Phase 1 • Sponsor: Microbiotica Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Heart patients get a sleep and stress boost in rehab trial
Symptom relief Recruiting nowThe primary objective of this project is to investigate the effectiveness and costs of integrating a behavioural program targeting sleep and stress (the RESST intervention) into cardiac rehabilitation (CR). In addition, the investigators will also study whether parameters regardi…
Sponsor: Erasmus Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New app connects young cancer survivors for support after treatment
Symptom relief Recruiting nowAdolescents and young adults (AYA) diagnosed with cancer experience unique challenges after completing treatment and face distinct barriers to optimal care and support. These challenges include higher levels of symptom burden and treatment complications, interrupted education, ca…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Yoga vs. physio: new study tests which is better for back pain and stiffness
Symptom relief Recruiting nowA few studies have evaluated the effectiveness of yoga therapy in patients with axial spondyloarthritis (axSPA). On the other hand, studies conducted in other chronic rheumatisms such as low back pain, rheumatoid arthritis or other conditions such as cancer have shown that yogath…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New study aims to make behavioral support for autistic kids work in schools
Knowledge-focused CompletedThe increased prevalence of autism spectrum disorder (1 in 36 youth) in the United States along with the exorbitant cost of care of supporting one autistic individual with and without intellectual disability across their lifespan ($2.4 and $1.4 million, respectively) creates a se…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Tai chi and tech team up to get heart patients moving
Symptom relief CompletedThis projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.
Phase 2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Aug 08, 2026 00:03 UTC
-
Could ecstasy help treat narcissism? small study explores MDMA therapy
Symptom relief OngoingThis open-label, proof-of-concept pilot study will assess the efficacy and safety of midomafetamine (MDMA) - assisted therapy (AT) for participants diagnosed with pathological narcissism. As all participants will be allocated to a single group assignment, there will be no blindin…
Early phase 1 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
EHR alerts aim to close gap in heart valve care
Knowledge-focused CompletedThis multi-center, prospective, cluster-randomized controlled trial will evaluate Tempus Next automated notifications as an intervention to support identification and evaluation of patients possibly indicated for Valve Intervention (VI). This study will evaluate the impact of Tem…
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New therapy aims to beat depression relapse
Symptom relief Recruiting nowConduct a pilot, single-center, randomized controlled 2-arm study aimed to evaluate the impact of an in-depth 3rd wave CBT program targeting correct self-identification (3rd level of 3rd wave CBT), compared to a control group receiving an acceptance and commitment therapy (ACT; (…
Sponsor: University Hospital, Montpellier • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New drug BL-B16D1 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open, multicenter, increasing dose and dose extension nonrandomized phase I clinical study to evaluate the safety, tolerability, pharmacokinetics characteristics and preliminary efficacy of BL-B16D1 in patients with unresectable locally advanced or metastatic bre…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:48 UTC
-
Robotic knee surgery vs. total knee replacement: which is better?
Disease control Recruiting nowThe purpose of this research is to compare the functional outcomes of patients with end stage medial compartment OA of the knee undergoing a conventional mTKA to those undergoing rUKA and to assess the associated cost economics of such technology.
Sponsor: NHS Lothian • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC